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A 23-year-old woman was referred to our 
department complaining of intermittent double 
vision for 3 weeks. Best corrected visual acuity 
(BCVA) was 20/20 in both eyes (OU), the pupils 
were round and reactive to light with no relative 
afferent pupillary defect (RAPD), intraocular 
pressure (IOP) was 12mmHg OU; color vision 
by Ishihara pseudo-isochromatic plates and 
automated visual fields (Figure 1) were normal 
OU, as well. Orthoptic examination showed slight 
limitation of abduction and partial sixth nerve 
palsy in the left eye (OS). Dilated fundoscopy 
revealed bilateral optic disc edema (Figure 2). 
A high dose steroid (methylprednisolone) was 
initially administered with the clinical suspicion 
of an underlying neuro–inflammatory process.
Magnetic resonance imaging (MRI) excluded 
intracranial masses, hemorrhage, meningitis 
or other similar conditions causing optic disc 
edema. Lumbar puncture revealed elevated 
cerebrospinal fluid (CSF) opening pressure at 
46 mmHg (normal up to 16 mmHg) with no 
abnormal constituents, therefore papilledema 
was verified. There was no history of weight 
gain, obesity, migraine headaches or tobacco 
use. The patient had been using an oral birth 
control pill, Yasmin 28 (drospirenone and ethinyl 
estradiol) over the past 5 months.
No abnormal findings were detected on 
an extensive hematology panel including 
erythrocyte sedimentation rate (ESR), complete 
blood count (CBC), kidney function, C-reactive 
protein (CRP) and partial thomboplastin time 
(PTT). Magnetic resonance venography (MRV) 
showed partial venous thrombosis of the right 
transverse and sigmoid sinuses (Figure 3).
Fraxiforte® (nadroparin calcium) injections 
0.4 ml once daily, Sintrom® (acenocoumarol) 
and acetazolamide 250mg twice daily were 
administered as initial treatment and the steroid 
was tapered. One week later, BCVA and color 
vision were stable at 20/20 OU and 13/13 OU, 
respectively. Six months later the fundoscopic 
appearance improved, Sintrom® was 
discontinued and acetazolamide was reduced 
to 250mg daily for 1 month and 125mg daily for 
the next month. Ten months after the episode, 
the patient was clinically stable and optic disc 
edema had completely regressed (Figure 4).
Figure 1. Visual field testing (Octopus): no significant 
defects were detected in the right (upper image) and left 
(lower image) eyes.
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DISCUSSION
The mechanism of increased intracranial 
pressure in cerebral venous sinus thrombosis 
(CVST) is compromised venous drainage. 
Subsequently, disruption of the blood brain 
barrier occurs resulting in vasogenic edema, 
which may be compounded by neuronal 
swelling from localized ischemia and damage to 
the intracellular ion channels.1 Large areas of the 
brain can be compromised, but not necessarily 
irreversibly damaged.
The association of anovulatory agents and 
venous thromboembolism (VTE) is well-defined 
in literature.2-5 Van Vlijmen et al5 reported the 
effects of combined oral contraceptives on the 
Figure 2. Dilated fundoscopy: bilateral optic disc edema at presentation.
Figure 3. Magnetic resonance venography demonstrates partial venous thrombosis of the right transverse and sigmoid 
sinuses (arrows).
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absolute risk of VTE in women with single or 
multiple thrombophilic disorders such as protein 
S and C deficiencies. The annual incidence of 
VTE without the use of anovulatory agents 
was 1.64% in patients with such deficiencies as 
compared to 0.18% in normal women. The use of 
oral contraceptives almost triples the incidence 
of VTE in both populations. Mira et al3 reported 
40 cases of VTE among women taking Yasmin 28 
(drospirenone and ethinyl estradiol), including 2 
fatal cases. Therefore, women with predisposing 
factors for VTE are strongly recommended to 
avoid using oral contraceptives.3,5
In addition, patients with a history of 
smoking or migraine who use oral contraceptives 
may be at higher risk for CVST. The direct role of 
these risk factors on the development of CVST is 
not well-established yet; however a higher risk 
Figure 4. Dilated fundoscopy: resolution of optic disc edema in both eyes, ten months later.
Figure 5. Dilation (arrows) of the sheaths of the optic nerves (left image) and concave appearance of the pituitary gland 
(right image).
Photo Essay; Panos et al
284 JOURNAL OF OPHTHALMIC AND VISION RESEARCH 2014; Vol. 9, No. 2
of cardiovascular events and ischemic stroke has 
been reported.2,4 Migraine alone is a strong risk 
factor. When accompanied by smoking and oral 
contraceptive use, the risk of ischemic stroke 
increases considerably.2
Our patient had no history of smoking, 
migraines, obesity or thrombophilic disorders. 
She was complaining of only one symptom: 
double vision. Diplopia, due to 6th nerve palsy, 
could be explained by intracranial hypertension 
further manifesting as dilation of the optic 
nerves sheaths and concavity of the pituitary 
gland (Figure 5). Interestingly, our patient had 
no headache which is a common symptom in 
CVST.6 The patient was initially misdiagnosed as 
a case of optic neuritis, but further investigation 
with MRI, MRV and lumbar puncture established 
the correct diagnosis of CVST.
This case highlights that CVST may present 
with atypical symptoms such as diplopia. The 
history of oral contraceptive use is of high 
importance for diagnosing CVST among young 
women. Imaging techniques are crucial for 
prompt diagnosis and appropriate treatment 
as illustrated in this case report.
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